Antibodies
New end-to-end compliant-ready workflow helps biotherapeutic protein manufacturers meet regulatory and attribute-based product analysis requirements for drug identity, purity, and quality
| 2 min read
Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases
| 2 min read
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline
| 1 min read
Worrisome new coronavirus variants can evade antibodies that neutralize original virus, recent lab research shows
| 4 min read
These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines
| 2 min read
Panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples
| 1 min read
Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects
| 1 min read
The new Antibody Discovery Module accelerates and improves candidate selection workflows
| 2 min read
Conjugated antibodies for flow cytometry is an essential tool that requires validation
| 4 min read
Antibody validation and quality control strategies ensure high specificity and reproducibility for optimal performance
| 1 min read
Scientists have developed a novel strategy that redirects antibodies for other diseases existing in humans to the spike proteins of SARS-CoV-2
| 2 min read
